Healthcare Industry Today

1. Oncternal Therapeutics Announces Presentation of Interim Clinical Data on TK216, its First-in-class, Targeted ETS Inhibitor, in Patients with Relapsed or Refractory Ewing Sarcoma at the CTOS 2019 Annual Meeting

   … Meyers. “Advanced, refractory Ewing sarcoma is a serious and devastating … in most cases of Ewing sarcoma. ETS-related translocations or … the treatment of Ewing sarcoma. TK216 is an investigational … relapsed or refractory Ewing sarcoma, a rare pediatric cancer …

2. Do You Have News to Share? Get It Published.

   With EIN Presswire press release distribution services you will reach decision makers and journalists plus get valuable SEO benefits.

3. Athenex Announces European Commission Grants Orphan Designations for Paclitaxel and Encequidar for the Treatment of Soft Tissue Sarcoma

   … the treatment of soft tissue sarcoma, following a positive opinion from … , a form of soft tissue sarcoma, that showed rapid responses in …

4. Courage Ride Donates $100,000 to the University of Iowa Holden Comprehensive Cancer Center Sarcoma Research Program

   … Holden Comprehensive Cancer Center Sarcoma Research Program. Courage Ride … dollars have seeded numerous sarcoma-research grants, several that … into larger, more-extensive sarcoma-research studies, and … raise research dollars for sarcoma cancer. The event, …

5. Ewing sarcoma: What to know

   … options. Share on PinterestEwing sarcoma commonly occurs in the legs … treatments. Possible treatments for Ewing sarcoma include: Chemotherapy: Chemotherapy uses medications … treatments. Possible complications of Ewing sarcoma include: pleural effusion, which …